Jay Thakkar of Sharekhan advises buying Dr Reddy's Laboratories with a target of Rs 4390.

Buy Bosch, Ajanta Pharma: Manas Jaiswal

Manas Jaiswal of manasjaiswal.com recommends buying Bosch and Ajanta Pharma.

Bull's Eye: Buy Gruh Fin, JSPL, Voltas, Pidilite, DCB Bank

According to Dharmesh Kant of India Nivesh Securities, one may buy Gateway Distriparks with a target of Rs 390.

Super Six: Top chart picks for July 28

Kunal Saraogi of Equityrush is of the view that one may sell ICICI Bank with a target of Rs 284.

Overweight on pharma, private sector banks: Dipan Mehta

Dipan Mehta - member at BSE & NSE maintains overweight position on pharma as well as private sector banks.

Bull's Eye: Buy Hotel Leela, GMDC, Mindtree, sell OBC

Jay Thakkar of Sharekhan suggests buying Indraprastha Gas with a target of Rs 484.

Look at La Opala; buy Ajanta Pharma: CK Narayan

CK Narayan of Growth Avenues is of the view that one can buy Ajanta Pharma and feels that one may look at La Opala, Force Motors and Tata Elxsi.

Ajanta Pharma may test Rs 1725, says Manas Jaiswal

According to Manas Jaiswal of manasjaiswal.com, Ajanta Pharma may test Rs 1725.

Sell Ajanta Pharma, CESC; buy Union Bank: Hemen Kapadia

Hemen Kapadia, VP at KR Choksey Securities recommends selling Ajanta Pharma and CESC and advises buying Union Bank of India.

Check out: Top 10 stocks of the day

Here's a list of top 10 stocks that are in news today due to fourth quarter earnings, entry into F&O segment and merger deals.

Dipan Mehta cautious on midcap IT & pharma

Dipan Mehta, member at BSE & NSE has a cautious view on midcap IT and midcap pharma.

Prefer Ajanta Pharma: Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com is of the view that Ajanta Pharma is an active investing idea.

Bull's eye: Buy Dabur, LIC Housing, Concor, Hexaware

Paras Bothra of Ashika Stock Broking recommends buying Arvind for a target price of Rs 320 and Hexaware Technologies for a target price of Rs 250.

Book profits in Ajanta Pharma: SP Tulsian

SP Tulsian of sptulsian.com is of the view that one may book profits in Ajanta Pharma.

Avoid Aurobindo Pharma: Pritesh Mehta

Pritesh Mehta of IIFL is of the view that one may avoid Aurobindo Pharma.

Buy Ajanta Pharma, advises Sudarshan Sukhani

Sudarshan Sukhani of s2analytics.com recommends buying Ajanta Pharma as the stock may head higher.

Cautious on Ajanta Pharma, may go to Rs 1250-1300: Tulsian

SP Tulsian of sptulsian.com said he would definitely be taking the cautious stance on Ajanta Pharma.

Expect Ajanta Pharma to touch lifetime highs: Sukhani

Sudarshan Sukhani of s2analytics.com advises to build a position in Ajanta Pharma and then carry it for few days.

Buy Ajanta Pharma, Kolte-Patil, Jet Airways: Tulsian

In CNBC-TV18's popular show Bull's Eye, SP Tulsian, sptulsian.com shares his trading strategies for the day.

Bull's Eye: Buy Bank of Maha, Jet, Kolte-Patil, Tata Global

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Buy Ajanta Pharma, IGL; sell Crompton Greaves: SP Tulsian

In CNBC-TV18's popular show Bull's Eye, SP Tulsian of sptulsian.com shares trading strategy of the day.

Bull's eye: Buy Ajanta Pharma, Bharat Forge; short Unitech

Bull's Eye, CNBC-TV18's popular game show, where market experts come together to dish out trading strategies for you to make your week more exciting and compete with each other to see whose portfolio is the strongest.

Stay away from Ajanta Pharma, Sasken: SP Tulsian

SP Tulsian, sptulsian.com advises traders to stay away from Ajanta Pharma and Sasken.

Ajanta Pharma has target of Rs 500: SP Tulsian

Ajanta Pharma has target of Rs 500, says SP Tulsian, sptulsian.com.

Ajanta Pharma has target of Rs 425: PN Vijay

Ajanta Pharma has target of Rs 425 in the next 12 months, says PN Vijay, Portfolio Manager.